이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

TerrAscend 배당금

배당금 기준 확인 0/6

TerrAscend 배당금을 지급한 기록이 없습니다.

주요 정보

n/a

배당 수익률

n/a

지급 비율

업계 평균 수익률	2.1%
다음 배당금 지급일	n/a
전 배당일	n/a
주당 배당금	n/a
주당 순이익	-CA$0.27
3년 후 배당 수익률 예측	n/a

최근 배당금 업데이트

업데이트 없음

Recent updates

TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt

Apr 25

What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash

Mar 10

TerrAscend Corp.'s (CSE:TER) Earnings Haven't Escaped The Attention Of Investors

Jul 03

TerrAscend (CSE:TER) Is Making Moderate Use Of Debt

Mar 06

Is There An Opportunity With TerrAscend Corp.'s (CSE:TER) 37% Undervaluation?

Dec 21

Some Analysts Just Cut Their TerrAscend Corp. (CSE:TER) Estimates

Aug 14

Is TerrAscend (CSE:TER) Using Too Much Debt?

Jul 15

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: 과거에 TSND 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.

배당금 증가: TSND 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.

시장 대비 배당 수익률

TerrAscend 시장 대비 배당 수익률

TSND 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트	배당 수익률
회사 (TSND)	n/a
시장 하위 25% (CA)	1.8%
시장 상위 25% (CA)	6.1%
업계 평균 (Pharmaceuticals)	2.1%
3년 후 애널리스트 예측 (TSND)	n/a

주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 TSND 의 배당 수익률을 평가할 수 없습니다.

고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 TSND 의 배당 수익률을 평가할 수 없습니다.

주주에 대한 수익 배당금

수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 TSND 의 지급 비율을 계산하기에는 데이터가 부족합니다.

주주에 대한 현금 배당금

현금 흐름 범위: TSND 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.

TerrAscend 배당금

배당금 기준 확인 0/6

주요 정보

최근 배당금 업데이트

Recent updates

TerrAscend Corp. (TSX:TSND) announces an Equity Buyback for 10,000,000 shares, representing 3.43% for $10 million.

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

New minor risk - Shareholder dilution

TerrAscend Corp. to Report Q2, 2024 Results on Aug 08, 2024

New minor risk - Shareholder dilution

New minor risk - Share price stability

Now 23% overvalued after recent price rise

First quarter 2024 earnings: EPS misses analyst expectations

Terrascend Corp. Launches Legend Mini Pre-Roll Packs in New Jersey

TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates have been downgraded.

TerrAscend Corp. to Report Q1, 2024 Results on May 09, 2024

TerrAscend Corp., Annual General Meeting, Jun 17, 2024

New minor risk - Shareholder dilution

Full year 2023 earnings: EPS misses analyst expectations

What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash

TerrAscend Corp. to Report Fiscal Year 2023 Results on Mar 14, 2024

Revenues Tell The Story For TerrAscend Corp. (TSE:TSND) As Its Stock Soars 25%

TerrAscend Corp. Announces the Expansion of its Valhalla Product Offering to Include One of the First 100Mg Edibles in the Keystone State

New minor risk - Shareholder dilution

Is TerrAscend (TSE:TSND) A Risky Investment?

New minor risk - Shareholder dilution

TerrAscend Corp. Raises Earnings Guidance for 2023

TerrAscend Corp. to Report Q3, 2023 Results on Nov 09, 2023

New minor risk - Shareholder dilution

Consensus EPS estimates fall by 17%

New minor risk - Profitability

TerrAscend (TSE:TSND) Is Carrying A Fair Bit Of Debt

Second quarter 2023 earnings: EPS misses analyst expectations

TerrAscend Corp. Reports Impairment for the Second Quarter Ended June 30, 2023

New minor risk - Profitability

TerrAscend Corp. to Report Q2, 2023 Results on Aug 10, 2023

TerrAscend Corp. (CNSX:TER) acquired Herbiculture Inc. for $8.25 million.

TerrAscend Corp.'s (CSE:TER) Earnings Haven't Escaped The Attention Of Investors

TerrAscend Corp. (CNSX:TER) completed the acquisition of Derby 1, LLC.

TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Hempaid, LLC for $6.8 million.

TerrAscend Corp. announced that it expects to receive $15 million in funding

TerrAscend Corp. announced that it expects to receive $15 million in funding

TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Derby 1, LLC for $22.1 million.

An unknown buyer acquired Facility located in Mississauga, Canada from TerrAscend Corp. (CNSX:TER) for CAD19.7 million.

Consensus EPS estimates fall by 800%

First quarter 2023 earnings: EPS misses analyst expectations

Chief Financial Officer recently bought CA$99k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Director recently sold CA$59k worth of stock

TerrAscend (CSE:TER) Is Making Moderate Use Of Debt

Terrascend Appoints Jeroen De Beijer as Chief People and Culture Officer

TerrAscend Corp. (CNSX:TER) completed the acquisition of Allegany Medical Marijuana Dispensary from Moose Curve Holdings, LLC.

Now 25% undervalued after recent price drop

Is There An Opportunity With TerrAscend Corp.'s (CSE:TER) 37% Undervaluation?

Now 22% undervalued

TerrAscend Corp. Appoints Ira Duarte to Its Board of Directors

Consensus forecasts updated

Consensus EPS estimates fall by 1,223%

Less than half of directors are independent

TerrAscend Corp. to Report Q3, 2022 Results on Nov 14, 2022

Investor sentiment improved over the past week

Terrascend Corp. Announces Executive Changes

TerrAscend Corp. (CNSX:TER) acquired KISA Enterprises MI, LLC and KISA Holdings, LLC.

Consensus revenue estimates fall by 18%

Investor sentiment deteriorated over the past week

Some Analysts Just Cut Their TerrAscend Corp. (CSE:TER) Estimates

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

TerrAscend Corp. to Report Q2, 2022 Results on Aug 11, 2022

Consensus EPS estimates fall by 21%

Is TerrAscend (CSE:TER) Using Too Much Debt?

Less than half of directors are independent

TerrAscend Corp. Announces Launch of Khalifa Kush

Executive Chairman recently bought CA$89k worth of stock

TerrAscend Corp. (CNSX:TER) acquired Stadium Ventures, LLC.

Consensus EPS estimates fall by 150%

TerrAscend Launches First-Ever Concentrates in New Jersey

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

TerrAscend Appoints Lynn Gefen as Chief Legal Officer

Less than half of directors are independent